Salivary Proteomics Reveals Protein Changes During Multiple Sclerosis Treatment - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Salivary Proteomics Reveals Protein Changes During Multiple Sclerosis Treatment

  • November 16, 2026

  • 2 min

Share

  • 1

    The exploratory study analyzed saliva from 66 patients with relapsing-remitting multiple sclerosis (RRMS) before therapy and 31 healthy controls.

  • 2

    Of 623 proteins assessed statistically, 116 differed between patients with RRMS before treatment and healthy controls, compared with 54 after 6 months of therapy.

  • 3

    After 6 months, 38 proteins shifted toward control levels, 25 differed from controls only at follow-up, and 28 remained altered at both patient time points.

  • 4

    Altered proteins were linked to innate immunity, neutrophil degranulation, cytokine signaling, programmed cell death, and protein folding.

  • 5

    The 50-protein panel distinguished study groups within this cohort but is not ready for clinical use; larger multicenter studies are needed.

Original Source(s)

Related Content